Do black patients with chronic kidney disease benefit equally from all blood pressure lowering agents?
- PMID: 24429920
- PMCID: PMC4688567
- DOI: 10.1136/bmj.g142
Do black patients with chronic kidney disease benefit equally from all blood pressure lowering agents?
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Authors' reply to Ladapo and Ogedegbe.BMJ. 2014 Jan 15;348:g148. doi: 10.1136/bmj.g148. BMJ. 2014. PMID: 24429921 No abstract available.
Comment on
-
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.BMJ. 2013 Oct 3;347:f5680. doi: 10.1136/bmj.f5680. BMJ. 2013. PMID: 24092942 Free PMC article. Review.
References
-
- Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288:2421-31. - PubMed
-
- Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005;293:1595-608. - PubMed
-
- Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med 2004;141:614-27. - PubMed
-
- Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical